Revolution Medicines Inc [RVMD] stock prices are up 5.46% to $39.58 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RVMD shares have gain 1.98% over the last week, with a monthly amount drifted -2.70%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 08, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $63. Previously, Needham reaffirmed its Buy rating on April 12, 2024, and elevated its price target to $46. On April 10, 2024, upgrade upgraded it’s rating to Strong Buy and revised its price target to $48 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $43 on March 11, 2024. BofA Securities upgraded its rating to a Buy and raised its price target to $34 on January 05, 2024. Wedbush started tracking with a Outperform rating for this stock on January 04, 2024, and assigned it a price target of $41. In a note dated November 16, 2023, Raymond James initiated an Outperform rating and provided a target price of $30 on this stock.
The stock price of Revolution Medicines Inc [RVMD] has been fluctuating between $15.44 and $41.21 over the past year. Currently, Wall Street analysts expect the stock to reach $45.5 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $39.58 at the most recent close of the market. An investor can expect a potential return of 14.96% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
The Revolution Medicines Inc [NASDAQ:RVMD] reported sales of 4.57M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -1.09% with Operating Profit Margin at -121.09%, Pretax Profit Margin comes in at -106.83%, and Net Profit Margin reading is -106.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.36 and Total Capital is -0.3. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.81 points at the first support level, and at 38.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.16, and for the 2nd resistance point, it is at 40.75.
Ratios To Look Out For
It’s worth pointing out that Revolution Medicines Inc [NASDAQ:RVMD]’s Current Ratio is 18.45. Also, the Quick Ratio is 18.45, while the Cash Ratio stands at 3.08. Considering the valuation of this stock, the price to sales ratio is 1428.95, the price to book ratio is 3.78.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Jun 26 ’24 when 2000.0 shares were sold., Kelsey Stephen Michael completed a deal on Jun 25 ’24 to sell 16467.0 shares. Meanwhile, Kelsey Stephen Michael sold 200.0 shares on Jun 24 ’24.
